Abivax (ABVX) Share-based Compensation (2024 - 2026)
Abivax (ABVX) reported Share-based Compensation of $19.53 million for Q2 2026, up 172.4% from $7.17 million a year earlier but down 26.2% from the prior quarter.
Powered by 
Analysis
Abivax (ABVX) Share-based Compensation (2024 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Abivax's Share-based Compensation came in at $74.43 million, up 244.0% year-over-year; for FY2025, it came in at $39.99 million, up 82.7% from FY2024.
- Share-based Compensation has a four-year compound annual growth rate of 152.8% (FY2021 to FY2025).
- By year, Share-based Compensation came in at $21.89 million in FY2024 (+147.4%), $8.85 million in FY2023, -$1.23 million in FY2022 and $979,853 in FY2021.
- Five-year quarterly Share-based Compensation spans a low of $4.76 million in Q4 2024 and a high of $26.47 million in Q1 2026.
- Year over year, Share-based Compensation has now increased in each of the last five quarters, with growth averaging 167.0% over the last six quarters.
- Per Business Quant data, the three quarters before Q2 2026 came in at $26.47 million (Q1 2026), $15.02 million (Q4 2025) and $13.42 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 200.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 160.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 369.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 128.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 234.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 362.00 Mn |
| 10 | Abivax | 7.07 Bn | 4.69 Bn | - | 19.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.53 Mn |
| Mar 31, 2026 | 26.47 Mn |
| Dec 31, 2025 | 15.02 Mn |
| Sep 30, 2025 | 13.42 Mn |
| Jun 30, 2025 | 7.17 Mn |
| Mar 31, 2025 | 4.93 Mn |
| Dec 31, 2024 | 4.76 Mn |
| Sep 30, 2024 | 4.77 Mn |
| Jun 30, 2024 | 6.10 Mn |
| Mar 31, 2024 | 6.25 Mn |
API Access
Abivax Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ABVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "ABVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ABVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();